United States Biotechnology & Medical Research

Stoke Therapeutics Inc (STOK)

Track

Track

Over the past 90 days, Stoke Therapeutics Inc. has seen exclusively selling activity from insiders, totaling approximately $1.22 million in value. Key executives, including the Chief Medical Officer and General Counsel, conducted these transactions through planned and proposed sales. These activities occurred alongside an 11.2% decline in stock price over the same period.
Ticker: STOK Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Stoke Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
297.58
Quantity 95,027 -48.4%
Value US$4,570,455
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
219.86
Quantity 85,873 +29.9%
Value US$3,464,944
2.8
Kaye Edward M. MD Non-Executive Director
Transaction date
Sale
Price
276.28
Quantity 67,306 -31.4%
Value US$509,355
2.8
Kaye Edward M. MD Non-Executive Director
Transaction date
Sale
Price
32.01
Quantity 1,000 -8.7%
Value US$100,000
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Sale
Price
32.47
Quantity 1,000 -0.7%
Value US$100,000
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Sale
Price
32.01
Quantity 1,000 -11.3%
Value US$100,000
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
29.45
Quantity 1,000 -5.9%
Value US$100,000
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
28.95
Quantity 1,000 -21.4%
Value US$100,000
3.0
BARUCH TICHO Officer Officer
Transaction date
Proposed sale
Price
28.86
Quantity 1,000
Value US$100,000
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
33.27
Quantity 500 -1.8%
Value US$16,634
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
32.62
Quantity 6,728 -19.3%
Value US$219,434
3.0
BARUCH S. TICHO Officer Officer
Transaction date
Proposed sale
Price
32.72
Quantity 7,228
Value US$236,500
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Planned sale
Price
29.95
Quantity 1,457 -7.5%
Value US$43,637
2.9
JONATHAN D ALLAN Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 1,457
Value US$43,710
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
30.58
Quantity 1,795 -4.9%
Value US$54,891
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
32.79
Quantity 2,243 -5.8%
Value US$73,548
3.0
BARUCH S. TICHO Officer Officer
Transaction date
Proposed sale
Price
32.72
Quantity 4,038
Value US$132,123
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
32.66
Quantity 1,838 -4.5%
Value US$60,029
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
32.66
Quantity 1,838 -4.5%
Value US$60,029
3.0
BARUCH S. TICHO Officer Officer
Transaction date
Proposed sale
Price
32.56
Quantity 1,838
Value US$59,845
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Planned sale
Price
34.41
Quantity 601 -3.0%
Value US$20,679
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Planned sale
Price
33.64
Quantity 8,692 -30.1%
Value US$292,359
2.9
JONATHAN ALLAN Officer Officer
Transaction date
Proposed sale
Price
33.19
Quantity 9,293
Value US$308,435
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
29.99
Quantity 1,461 -3.5%
Value US$43,815
3.0
BARUCH S. TICHO Officer Officer
Transaction date
Proposed sale
Price
31.02
Quantity 1,461
Value US$45,320
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
32.85
Quantity 103 -0.3%
Value US$3,384
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
31.79
Quantity 483 -1.2%
Value US$15,354
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
31.28
Quantity 6,100 -12.8%
Value US$190,831
3.5
Hoitt Jason Chief Patient Officer Officer
Transaction date
Sale
Price
32.85
Quantity 30 -0.3%
Value US$986
3.5
Hoitt Jason Chief Patient Officer Officer
Transaction date
Sale
Price
31.79
Quantity 139 -1.3%
Value US$4,419
3.5
Hoitt Jason Chief Patient Officer Officer
Transaction date
Sale
Price
31.28
Quantity 1,762 -14.4%
Value US$55,122
2.4
Leggett Thomas Chief Financial Officer Officer
Transaction date
Sale
Price
32.85
Quantity 37 -0.4%
Value US$1,215
2.4
Leggett Thomas Chief Financial Officer Officer
Transaction date
Sale
Price
31.79
Quantity 172 -1.7%
Value US$5,468
2.4
Leggett Thomas Chief Financial Officer Officer
Transaction date
Sale
Price
31.28
Quantity 2,173 -17.3%
Value US$67,980
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Sale
Price
32.85
Quantity 72 -0.2%
Value US$2,365
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Sale
Price
31.79
Quantity 334 -1.1%
Value US$10,617
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Sale
Price
31.28
Quantity 4,222 -12.6%
Value US$132,080
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
33.38
Quantity 2,587 -5.2%
Value US$86,342
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
32.74
Quantity 3,577 -6.7%
Value US$117,109
3.5
Hoitt Jason Chief Patient Officer Officer
Transaction date
Sale
Price
33.38
Quantity 748 -5.8%
Value US$24,965
3.5
Hoitt Jason Chief Patient Officer Officer
Transaction date
Sale
Price
32.74
Quantity 1,033 -7.4%
Value US$33,820
2.4
Leggett Thomas Chief Financial Officer Officer
Transaction date
Sale
Price
33.38
Quantity 922 -6.8%
Value US$30,772
2.4
Leggett Thomas Chief Financial Officer Officer
Transaction date
Sale
Price
32.74
Quantity 1,274 -8.6%
Value US$41,710
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Sale
Price
33.38
Quantity 1,791 -5.1%
Value US$59,775
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Sale
Price
32.74
Quantity 2,476 -6.6%
Value US$81,063
1.2
LEVIN ARTHUR A Non-Executive Director
Transaction date
Planned sale
Price
36.80
Quantity 605 -12.5%
Value US$22,264
1.2
ARTHUR A LEVIN Director Non-Executive Director
Transaction date
Proposed sale
Price
36.48
Quantity 605
Value US$22,070
TZIANABOS ARTHUR Interim Executive Chair Executive Director
Transaction date
Planned sale
Price
40.00
Quantity 4,355 -12.2%
Value US$174,214
Krainer Adrian R. Non-Executive Director
Transaction date
Planned sale
Price
39.74
Quantity 33,243 -10.5%
Value US$1,320,964
ARTHUR TZIANABOS Director Non-Executive Director
Transaction date
Proposed sale
Price
38.31
Quantity 90,508
Value US$3,467,361
Krainer Adrian R. Non-Executive Director
Transaction date
Planned sale
Price
39.66
Quantity 7,229 -2.2%
Value US$286,715
Adrian Krainer Director Non-Executive Director
Transaction date
Proposed sale
Price
36.41
Quantity 40,472
Value US$1,473,586
2.8
Kaye Edward M. MD Non-Executive Director
Transaction date
Planned sale
Price
33.10
Quantity 1,331 -2.6%
Value US$44,062
2.8
Kaye Edward M. MD Non-Executive Director
Transaction date
Planned sale
Price
32.52
Quantity 8,274 -14.1%
Value US$269,070
2.8
Kaye Edward M. MD Non-Executive Director
Transaction date
Planned sale
Price
31.44
Quantity 3,825 -6.1%
Value US$120,253
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Planned sale
Price
32.61
Quantity 2,678 -18.5%
Value US$87,337
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Planned sale
Price
31.60
Quantity 1,300 -8.2%
Value US$41,074
2.8
EDWARD M KAYE Director Non-Executive Director
Transaction date
Proposed sale
Price
30.87
Quantity 13,430
Value US$414,584
2.9
JONATHAN ALLAN Officer Officer
Transaction date
Proposed sale
Price
30.87
Quantity 3,978
Value US$122,801
2.8
EDWARD M KAYE Director Non-Executive Director
Transaction date
Proposed sale
Price
31.05
Quantity 2,181
Value US$67,720
2.9
JONATHAN ALLAN Officer Officer
Transaction date
Proposed sale
Price
31.05
Quantity 7,781
Value US$241,600
3.0
BARUCH TICHO Officer Officer
Transaction date
Proposed sale
Price
31.05
Quantity 1,989
Value US$61,758
2.8
Kaye Edward M. MD Non-Executive Director
Transaction date
Planned sale
Price
31.85
Quantity 500 -0.8%
Value US$15,923
2.8
Kaye Edward M. MD Non-Executive Director
Transaction date
Planned sale
Price
31.15
Quantity 1,681 -2.6%
Value US$52,358
2.8
Kaye Edward M. MD Non-Executive Director
Transaction date
Sale
Price
31.33
Quantity 6,367 -9.0%
Value US$199,481
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
31.35
Quantity 1,989 -9.1%
Value US$62,346
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
31.33
Quantity 1,673 -7.1%
Value US$52,416
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Planned sale
Price
31.76
Quantity 2,344 -12.9%
Value US$74,445
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Planned sale
Price
31.08
Quantity 5,437 -23.0%
Value US$168,997
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Sale
Price
31.33
Quantity 1,004 -4.1%
Value US$31,456
2.8
Kaye Edward M. MD Non-Executive Director
Transaction date
Sale
Price
31.32
Quantity 1,231 -1.7%
Value US$38,550
2.8
Kaye Edward M. MD Non-Executive Director
Transaction date
Sale
Price
30.76
Quantity 5,222 -6.7%
Value US$160,647
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
31.32
Quantity 323 -1.4%
Value US$10,115
3.0
Ticho Barry CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
30.76
Quantity 1,373 -5.5%
Value US$42,238
2.9
Allan Jonathan GENERAL COUNSEL & CORP SEC Officer
Transaction date
Sale
Price
31.32
Quantity 194 -0.8%
Value US$6,075
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-18 2026-08-18 S Sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
95,027 -48.4%
297.58
US$4,570,455 		95,027 -48.4% 297.58 US$4,570,455
2026-08-18 2026-08-18 S Sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
85,873 +29.9%
219.86
US$3,464,944 		85,873 +29.9% 219.86 US$3,464,944
2026-08-18 2026-08-18 S Sale
2.8
Kaye Edward M. MD
Non-Executive Director
67,306 -31.4%
276.28
US$509,355 		67,306 -31.4% 276.28 US$509,355
2026-08-18 2026-08-18 S Sale
2.8
Kaye Edward M. MD
Non-Executive Director
1,000 -8.7%
32.01
US$100,000 		1,000 -8.7% 32.01 US$100,000
2026-08-18 2026-08-18 S Sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
1,000 -0.7%
32.47
US$100,000 		1,000 -0.7% 32.47 US$100,000
2026-08-18 2026-08-18 S Sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
1,000 -11.3%
32.01
US$100,000 		1,000 -11.3% 32.01 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,000 -5.9%
29.45
US$100,000 		1,000 -5.9% 29.45 US$100,000
2026-08-05 2026-08-03 PlS Planned sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,000 -21.4%
28.95
US$100,000 		1,000 -21.4% 28.95 US$100,000
2026-08-03 2026-08-03 PrS Proposed sale
3.0
BARUCH TICHO

Officer

Officer
1,000
28.86
US$100,000 		1,000 28.86 US$100,000
2026-07-06 2026-07-01 PlS Planned sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
500 -1.8%
33.27
US$16,634 		500 -1.8% 33.27 US$16,634
2026-07-06 2026-07-01 PlS Planned sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
6,728 -19.3%
32.62
US$219,434 		6,728 -19.3% 32.62 US$219,434
2026-07-01 2026-07-01 PrS Proposed sale
3.0
BARUCH S. TICHO

Officer

Officer
7,228
32.72
US$236,500 		7,228 32.72 US$236,500
2026-06-18 2026-06-16 PlS Planned sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
1,457 -7.5%
29.95
US$43,637 		1,457 -7.5% 29.95 US$43,637
2026-06-16 2026-06-16 PrS Proposed sale
2.9
JONATHAN D ALLAN

Officer

Officer
1,457
30.00
US$43,710 		1,457 30.00 US$43,710
2026-06-03 2026-06-01 PlS Planned sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,795 -4.9%
30.58
US$54,891 		1,795 -4.9% 30.58 US$54,891
2026-05-05 2026-05-01 PlS Planned sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
2,243 -5.8%
32.79
US$73,548 		2,243 -5.8% 32.79 US$73,548
2026-05-01 2026-05-01 PrS Proposed sale
3.0
BARUCH S. TICHO

Officer

Officer
4,038
32.72
US$132,123 		4,038 32.72 US$132,123
2026-04-03 2026-04-01 PlS Planned sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,838 -4.5%
32.66
US$60,029 		1,838 -4.5% 32.66 US$60,029
2026-04-03 2026-04-01 PlS Planned sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,838 -4.5%
32.66
US$60,029 		1,838 -4.5% 32.66 US$60,029
2026-04-01 2026-04-01 PrS Proposed sale
3.0
BARUCH S. TICHO

Officer

Officer
1,838
32.56
US$59,845 		1,838 32.56 US$59,845
2026-03-24 2026-03-20 PlS Planned sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
601 -3.0%
34.41
US$20,679 		601 -3.0% 34.41 US$20,679
2026-03-24 2026-03-20 PlS Planned sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
8,692 -30.1%
33.64
US$292,359 		8,692 -30.1% 33.64 US$292,359
2026-03-20 2026-03-20 PrS Proposed sale
2.9
JONATHAN ALLAN

Officer

Officer
9,293
33.19
US$308,435 		9,293 33.19 US$308,435
2026-03-19 2026-03-19 PlS Planned sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,461 -3.5%
29.99
US$43,815 		1,461 -3.5% 29.99 US$43,815
2026-03-19 2026-03-19 PrS Proposed sale
3.0
BARUCH S. TICHO

Officer

Officer
1,461
31.02
US$45,320 		1,461 31.02 US$45,320
2026-03-19 2026-03-18 S Sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
103 -0.3%
32.85
US$3,384 		103 -0.3% 32.85 US$3,384
2026-03-19 2026-03-18 S Sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
483 -1.2%
31.79
US$15,354 		483 -1.2% 31.79 US$15,354
2026-03-19 2026-03-18 S Sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
6,100 -12.8%
31.28
US$190,831 		6,100 -12.8% 31.28 US$190,831
2026-03-19 2026-03-18 S Sale
3.5
Hoitt Jason

Chief Patient Officer

Officer
30 -0.3%
32.85
US$986 		30 -0.3% 32.85 US$986
2026-03-19 2026-03-18 S Sale
3.5
Hoitt Jason

Chief Patient Officer

Officer
139 -1.3%
31.79
US$4,419 		139 -1.3% 31.79 US$4,419
2026-03-19 2026-03-18 S Sale
3.5
Hoitt Jason

Chief Patient Officer

Officer
1,762 -14.4%
31.28
US$55,122 		1,762 -14.4% 31.28 US$55,122
2026-03-19 2026-03-18 S Sale
2.4
Leggett Thomas

Chief Financial Officer

Officer
37 -0.4%
32.85
US$1,215 		37 -0.4% 32.85 US$1,215
2026-03-19 2026-03-18 S Sale
2.4
Leggett Thomas

Chief Financial Officer

Officer
172 -1.7%
31.79
US$5,468 		172 -1.7% 31.79 US$5,468
2026-03-19 2026-03-18 S Sale
2.4
Leggett Thomas

Chief Financial Officer

Officer
2,173 -17.3%
31.28
US$67,980 		2,173 -17.3% 31.28 US$67,980
2026-03-19 2026-03-18 S Sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
72 -0.2%
32.85
US$2,365 		72 -0.2% 32.85 US$2,365
2026-03-19 2026-03-18 S Sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
334 -1.1%
31.79
US$10,617 		334 -1.1% 31.79 US$10,617
2026-03-19 2026-03-18 S Sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
4,222 -12.6%
31.28
US$132,080 		4,222 -12.6% 31.28 US$132,080
2026-03-19 2026-03-17 S Sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
2,587 -5.2%
33.38
US$86,342 		2,587 -5.2% 33.38 US$86,342
2026-03-19 2026-03-17 S Sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
3,577 -6.7%
32.74
US$117,109 		3,577 -6.7% 32.74 US$117,109
2026-03-19 2026-03-17 S Sale
3.5
Hoitt Jason

Chief Patient Officer

Officer
748 -5.8%
33.38
US$24,965 		748 -5.8% 33.38 US$24,965
2026-03-19 2026-03-17 S Sale
3.5
Hoitt Jason

Chief Patient Officer

Officer
1,033 -7.4%
32.74
US$33,820 		1,033 -7.4% 32.74 US$33,820
2026-03-19 2026-03-17 S Sale
2.4
Leggett Thomas

Chief Financial Officer

Officer
922 -6.8%
33.38
US$30,772 		922 -6.8% 33.38 US$30,772
2026-03-19 2026-03-17 S Sale
2.4
Leggett Thomas

Chief Financial Officer

Officer
1,274 -8.6%
32.74
US$41,710 		1,274 -8.6% 32.74 US$41,710
2026-03-19 2026-03-17 S Sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
1,791 -5.1%
33.38
US$59,775 		1,791 -5.1% 33.38 US$59,775
2026-03-19 2026-03-17 S Sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
2,476 -6.6%
32.74
US$81,063 		2,476 -6.6% 32.74 US$81,063
2026-03-17 2026-03-13 PlS Planned sale
1.2
LEVIN ARTHUR A
Non-Executive Director
605 -12.5%
36.80
US$22,264 		605 -12.5% 36.80 US$22,264
2026-03-13 2026-03-13 PrS Proposed sale
1.2
ARTHUR A LEVIN

Director

Non-Executive Director
605
36.48
US$22,070 		605 36.48 US$22,070
2026-03-12 2026-03-10 PlS Planned sale
TZIANABOS ARTHUR

Interim Executive Chair

Executive Director
4,355 -12.2%
40.00
US$174,214 		4,355 -12.2% 40.00 US$174,214
2026-03-12 2026-03-10 PlS Planned sale
Krainer Adrian R.
Non-Executive Director
33,243 -10.5%
39.74
US$1,320,964 		33,243 -10.5% 39.74 US$1,320,964
2026-03-10 2026-03-10 PrS Proposed sale
ARTHUR TZIANABOS

Director

Non-Executive Director
90,508
38.31
US$3,467,361 		90,508 38.31 US$3,467,361
2026-03-04 2026-03-02 PlS Planned sale
Krainer Adrian R.
Non-Executive Director
7,229 -2.2%
39.66
US$286,715 		7,229 -2.2% 39.66 US$286,715
2026-03-02 2026-03-02 PrS Proposed sale
Adrian Krainer

Director

Non-Executive Director
40,472
36.41
US$1,473,586 		40,472 36.41 US$1,473,586
2025-12-10 2025-12-08 PlS Planned sale
2.8
Kaye Edward M. MD
Non-Executive Director
1,331 -2.6%
33.10
US$44,062 		1,331 -2.6% 33.10 US$44,062
2025-12-10 2025-12-08 PlS Planned sale
2.8
Kaye Edward M. MD
Non-Executive Director
8,274 -14.1%
32.52
US$269,070 		8,274 -14.1% 32.52 US$269,070
2025-12-10 2025-12-08 PlS Planned sale
2.8
Kaye Edward M. MD
Non-Executive Director
3,825 -6.1%
31.44
US$120,253 		3,825 -6.1% 31.44 US$120,253
2025-12-10 2025-12-08 PlS Planned sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
2,678 -18.5%
32.61
US$87,337 		2,678 -18.5% 32.61 US$87,337
2025-12-10 2025-12-08 PlS Planned sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
1,300 -8.2%
31.60
US$41,074 		1,300 -8.2% 31.60 US$41,074
2025-12-08 2025-12-08 PrS Proposed sale
2.8
EDWARD M KAYE

Director

Non-Executive Director
13,430
30.87
US$414,584 		13,430 30.87 US$414,584
2025-12-08 2025-12-08 PrS Proposed sale
2.9
JONATHAN ALLAN

Officer

Officer
3,978
30.87
US$122,801 		3,978 30.87 US$122,801
2025-12-05 2025-12-05 PrS Proposed sale
2.8
EDWARD M KAYE

Director

Non-Executive Director
2,181
31.05
US$67,720 		2,181 31.05 US$67,720
2025-12-05 2025-12-05 PrS Proposed sale
2.9
JONATHAN ALLAN

Officer

Officer
7,781
31.05
US$241,600 		7,781 31.05 US$241,600
2025-12-05 2025-12-05 PrS Proposed sale
3.0
BARUCH TICHO

Officer

Officer
1,989
31.05
US$61,758 		1,989 31.05 US$61,758
2025-12-05 2025-12-05 PlS Planned sale
2.8
Kaye Edward M. MD
Non-Executive Director
500 -0.8%
31.85
US$15,923 		500 -0.8% 31.85 US$15,923
2025-12-05 2025-12-05 PlS Planned sale
2.8
Kaye Edward M. MD
Non-Executive Director
1,681 -2.6%
31.15
US$52,358 		1,681 -2.6% 31.15 US$52,358
2025-12-05 2025-12-05 S Sale
2.8
Kaye Edward M. MD
Non-Executive Director
6,367 -9.0%
31.33
US$199,481 		6,367 -9.0% 31.33 US$199,481
2025-12-05 2025-12-05 PlS Planned sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,989 -9.1%
31.35
US$62,346 		1,989 -9.1% 31.35 US$62,346
2025-12-05 2025-12-05 S Sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,673 -7.1%
31.33
US$52,416 		1,673 -7.1% 31.33 US$52,416
2025-12-05 2025-12-05 PlS Planned sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
2,344 -12.9%
31.76
US$74,445 		2,344 -12.9% 31.76 US$74,445
2025-12-05 2025-12-05 PlS Planned sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
5,437 -23.0%
31.08
US$168,997 		5,437 -23.0% 31.08 US$168,997
2025-12-05 2025-12-05 S Sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
1,004 -4.1%
31.33
US$31,456 		1,004 -4.1% 31.33 US$31,456
2025-12-05 2025-12-04 S Sale
2.8
Kaye Edward M. MD
Non-Executive Director
1,231 -1.7%
31.32
US$38,550 		1,231 -1.7% 31.32 US$38,550
2025-12-05 2025-12-04 S Sale
2.8
Kaye Edward M. MD
Non-Executive Director
5,222 -6.7%
30.76
US$160,647 		5,222 -6.7% 30.76 US$160,647
2025-12-05 2025-12-04 S Sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
323 -1.4%
31.32
US$10,115 		323 -1.4% 31.32 US$10,115
2025-12-05 2025-12-04 S Sale
3.0
Ticho Barry

CHIEF MEDICAL OFFICER

Officer
1,373 -5.5%
30.76
US$42,238 		1,373 -5.5% 30.76 US$42,238
2025-12-05 2025-12-04 S Sale
2.9
Allan Jonathan

GENERAL COUNSEL & CORP SEC

Officer
194 -0.8%
31.32
US$6,075 		194 -0.8% 31.32 US$6,075
Explore more

More insider trading research around Stoke Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America